Novartis | NOVN - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
AbbVie USD 3.59B 28.65B 2025-12
Alcon AG USD 968M 49M 2026-06
Almirall EUR 235.53M 22.52M 2026-06
Amgen USD 2.86B 16.65B 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Autolus Therapeutics Ltd USD 1.37M 506K 2026-06
Bayer EUR 6.39B 192M 2026-06
Biogen USD 403.9M 45.4M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Fresenius EUR 1.23B 25M 2026-06
Fresenius Medical Care EUR 891.84M 1.41M 2026-06
Genmab DKK 116M 110M 2026-06
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
GRIFOLS EUR 1B 160M 2026-06
Hikma Pharmaceutical USD 715M 104M 2025-12
J&J USD 9.22B 1.24B 2026-06
Lakefront Biotherapeutics EUR 66.35M 29.42M 2026-06
Lonza CHF 471M 3M 2024-12
Merck EUR 2.07B 61M 2026-06
Merck USD 3.83B 36M 2026-06
Novartis USD 4.26B 64M 2026-06
Novartis USD 4.32B 134M 2026-03
Novo Nordisk DKK 14.59B 212M 2026-06
Orion EUR 109M 41.3M 2026-06
Pfizer USD 4.58B 75M 2026-06
Philips EUR 2.08B 90M 2026-06
Recordati EUR 321.16M 14.26M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
UCB EUR 4.04B 755M 2025-12